{"id":"https://openalex.org/W2591925596","doi":"https://doi.org/10.1182/blood.v128.22.539.539","title":"Late Morbidity and Mortality Among 2-Year Survivors of Non-Hodgkin Lymphoma (NHL) Diagnosed in the Elderly - a Population-Based Study","display_name":"Late Morbidity and Mortality Among 2-Year Survivors of Non-Hodgkin Lymphoma (NHL) Diagnosed in the Elderly - a Population-Based Study","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2591925596","doi":"https://doi.org/10.1182/blood.v128.22.539.539","mag":"2591925596"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.539.539","doi":"https://doi.org/10.1182/blood.v128.22.539.539","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.539.539","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034413439","display_name":"Kelly Marie Kenzik","orcid":"https://orcid.org/0000-0002-6402-8446","observed_orcids":["https://orcid.org/0000-0002-6402-8446"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Kenzik","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitkumar Mehta","raw_affiliation_strings":["Hematology & Oncology, University of Alabama at Birmingham (UAB), Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology & Oncology, University of Alabama at Birmingham (UAB), Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003401361","display_name":"Joshua Richman","orcid":"https://orcid.org/0000-0002-6166-7488","observed_orcids":["https://orcid.org/0000-0002-6166-7488"]},"institutions":[{"id":"https://openalex.org/I17301866","display_name":"University of Alabama","ror":"https://ror.org/03xrrjk67","country_code":"US","type":"education","lineage":["https://openalex.org/I17301866"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Richman","raw_affiliation_strings":["Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I17301866","https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026316133","display_name":"Meredith L. Kilgore","orcid":"https://orcid.org/0000-0001-6127-5188","observed_orcids":["https://orcid.org/0000-0001-6127-5188"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith Kilgore","raw_affiliation_strings":["Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043738456","display_name":"Smita Bhatia","orcid":"https://orcid.org/0000-0002-7755-5683","observed_orcids":["https://orcid.org/0000-0002-7755-5683"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smita Bhatia","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.18753121,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"539","last_page":"539"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.31450000405311584,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.10249999910593033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/late-morbidity","display_name":"late morbidity","score":0.902999997138977},{"id":"https://openalex.org/keywords/late-mortality","display_name":"late mortality","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9629999995231628},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.8100000023841858},{"id":"https://openalex.org/keywords/competing-risk-analysis","display_name":"competing risk analysis","score":0.4009999930858612},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/radiation-exposure","display_name":"radiation exposure","score":0.4309999942779541},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6520000100135803},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.5849999785423279},{"id":"https://openalex.org/keywords/aggressive-lymphoma","display_name":"aggressive lymphoma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/seer-medicare-linkage","display_name":"SEER-Medicare linkage","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cause-specific-mortality","display_name":"cause-specific mortality","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8667592406272888},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6155063509941101},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.604260265827179},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.5168495774269104},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.5046602487564087},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49383196234703064},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4199987053871155},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32110148668289185},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.19407081604003906},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.539.539","doi":"https://doi.org/10.1182/blood.v128.22.539.539","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.539.539","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8899999856948853,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1978188354","https://openalex.org/W3141224953","https://openalex.org/W2155091457","https://openalex.org/W2765738011","https://openalex.org/W4387318495","https://openalex.org/W2002142585","https://openalex.org/W2157868280","https://openalex.org/W4240532399","https://openalex.org/W2795699014","https://openalex.org/W4307571190"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Over":[2],"55%":[3,255],"of":[4,21,79,87,155,252,270,298,331,361,402,417,435,449,453,528,543,558,602,630],"all":[5,418],"NHL":[6,23,51,97,119,130,191,242,405,465,510,521,572],"is":[7],"diagnosed":[8,53,98,116,279],"after":[9],"age":[10,55,88,189,240],"65y.":[11],"Declining":[12],"death":[13,530,545,549],"rates":[14],"have":[15,389],"resulted":[16],"in":[17,31,111,265,567],"a":[18,249,372,390,576,586],"growing":[19],"population":[20,33,272],"older":[22],"survivors.":[24],"However":[25],"the":[26,80,153,271,307,382,445,454,464,473,476,533,539,568,594],"long-term":[27,598],"morbidity":[28,45,157,300,560],"and":[29,46,65,69,76,101,103,136,168,209,230,262,287,365,420,485,517,551],"mortality":[30,47,229,582],"this":[32,39,112],"remains":[34],"unknown.":[35],"This":[36],"study":[37],"addresses":[38],"gap":[40],"by":[41,49],"evaluating":[42],"post-cancer":[43],"late":[44,228,529,581],"experienced":[48],"2y":[50,107,571],"survivors":[52,304,325,349,406,573],"at":[54,105,190,241,327,357,371,430,481,487,494,512,523,563,575],"\u226565,":[56],"using":[57],"data":[58],"from":[59,75,483],"SEER":[60],"linked":[61],"with":[62,95,179,248,280,368,508,519,532,585,604],"Medicare":[63,81],"claims,":[64],"an":[66,266,437,627],"age,":[67],"sex":[68],"race":[70],"frequency-matched":[71],"comparison":[72,308],"group":[73],"derived":[74],"representing":[77],"5%":[78],"non-cancer":[82,344,587],"population.":[83,345,536,588],"Methods":[84],"Individuals":[85],"\u226567y":[86],"(to":[89],"allow":[90],"for":[91,321,339,504,580,593,596],"identifying":[92],"pre-cancer":[93,210,322,505],"conditions)":[94],"incident":[96],"between":[99],"1/1/2000":[100],"12/31/2008":[102],"surviving":[104,472],"least":[106],"(n=10,958)":[108],"were":[109,115,149,223,256,259,278,326,356,370,384,413,429,511,522],"included":[110,183],"analysis.":[113],"Survivors":[114,377,424],"as":[117],"aggressive":[118,281,509],"(diffuse":[120],"large":[121],"B":[122],"cell,":[123,125],"Mantle":[124],"Burkitt's:":[126],"n=7,004)":[127],"or":[128,451,459,632],"indolent":[129,520],"(follicular,":[131],"marginal":[132],"zone,":[133],"chronic":[134],"lymphocytic":[135,139],"small":[137],"cell":[138],"leukemia:":[140],"n=3,954).":[141],"New-onset":[142,292],"morbidity:":[143,293],"Competing":[144],"risk":[145,330,338,360,375,516,527,579],"cumulative":[146,231,296,400,447,541],"incidence":[147,232,297,401,448,542,557],"functions":[148],"used":[150,224],"to":[151,225,233,306,343,381,388,393,440],"assess":[152],"development":[154],"new-onset":[156,180,299,333,455,559],"(congestive":[158],"heart":[159],"failure":[160],"[CHF],":[161],"cardiovascular":[162],"disease":[163],"[CVD:":[164],"stroke/":[165],"myocardial":[166],"infarction],":[167],"subsequent":[169],"malignant":[170],"neoplasms":[171],"[SMNs]).":[172],"Cox":[173],"regression":[174],"models":[175],"evaluated":[176],"predictors":[177],"associated":[178],"morbidity.":[181],"Predictors":[182],"lymphoma":[184],"type":[185],"(aggressive":[186],"vs.":[187,312,317],"indolent),":[188],"diagnosis,":[192],"stage,":[193],"sex,":[194],"SES,":[195],"race/ethnicity,":[196],"radiation":[197,290,380,396,428],"site,":[198],"chemotherapy":[199,205],"(none,":[200],"rituximab":[201],"only,":[202],"anthracycline":[203],"based":[204],"(ABC),":[206],"non-ABC":[207,369],"chemotherapy),":[208],"comorbidity":[211],"(Charlson":[212],"Comorbidity":[213],"Index":[214],"+":[215,217],"hypertension":[216],"depression).":[218],"Late":[219,468],"mortality:":[220,469],"Kaplan-Meier":[221],"methods":[222],"evaluate":[226,234],"all-cause":[227],"cause-specific":[235],"mortality.":[236],"Results:":[237],"The":[238,294,398,409,556],"median":[239,250],"diagnosis":[243,484,565],"was":[244,301,407,461,479,546],"76y":[245],"(range:":[246],"67-103)":[247],"survival":[251,478],"7y":[253],"(2-14y);":[254],"male,":[257],"90%":[258],"Non-Hispanic":[260],"White":[261],"39%":[263,283],"resided":[264],"area":[267],"where":[268],">10%":[269],"lived":[273],"below":[274],"poverty":[275],"level;":[276],"64%":[277],"NHL;":[282],"received":[284,289,354,379,426],"ABC":[285,355],"therapy":[286],"20%":[288],"(n=2,219).":[291],"10y":[295,399,446,540],"greater":[302],"among":[303,348,404,463],"compared":[305,342,392,439,531,584],"group:":[309],"CVD":[310,340,391],"(57.4%":[311],"53.8%,":[313],"p=<0.001),":[314],"CHF":[315,334,363],"(56.0%":[316],"43.1%,":[318],"p<0.001).":[319],"Controlling":[320,503],"comorbidities,":[323,506],"cancer":[324,415,422],"1.7-fold":[328],"increased":[329,337,359,374,433,515,526,578],"developing":[332,362,436],"(p<0.001),":[335],"1.16-fold":[336],"(p<0.001)":[341,364,432,514,525],"Multivariable":[346],"analysis":[347],"revealed":[350],"that":[351],"those":[352,366,394,441,518],"who":[353,378,425],"1.21-fold":[358],"treated":[367],"1.13-fold":[373],"(p=0.01).":[376],"chest/axilla":[383],"1.14-fold":[385],"more":[386,452],"likely":[387],"without":[395,442],"(p=0.03).":[397],"SMNs":[403,412],"21.6%.":[408],"most":[410],"common":[411],"lung":[414],"(13.1%":[416],"SMNs)":[419,460],"prostate":[421],"(11.2%).":[423],"any":[427],"1.37-fold":[431],"hazard":[434],"SMN":[438],"radiation.":[443],"Importantly,":[444],"one":[450],"morbidities":[456],"(CHF,":[457],"CHD":[458],"77.3%":[462],"(Fig":[466,501],"1).":[467],"Conditional":[470],"on":[471,626],"first":[474],"2y,":[475],"overall":[477],"61.2%":[480],"5y":[482],"35.8%":[486],"10y,":[488],"significantly":[489],"lower":[490],"than":[491],"matched":[492,534],"controls":[493],"equivalent":[495],"time":[496],"points":[497],"(78.7%,":[498],"57.5%;":[499],"p<0.0001)":[500],"2).":[502],"individuals":[507],"2.0-fold":[513],"1.9-fold":[524],"control":[535],"Among":[537],"survivors,":[538],"lymphoma-related":[544],"38.1%,":[547],"CVD-related":[548],"(19.9%)":[550],"SMN-related":[552],"deaths":[553],"(13.6%).":[554],"Conclusion":[555],"exceeds":[561],"75%":[562],"10yfrom":[564],"ofNHL":[566],"elderly.":[569],"Further,":[570],"are":[574],"2-fold":[577],"when":[583],"These":[589],"findings":[590],"provide":[591],"evidence":[592],"need":[595],"close":[597],"risk-based":[599],"medical":[600],"follow-up":[601],"elderly":[603],"NHL.":[605],"Figure":[606,608],"1":[607],"1.":[609],"Disclosures":[610],"Mehta:":[611],"Pharmacyclics:":[612],"Research":[613,616,621,637,640,643],"Funding;":[614,617,622,638,641],"Medimmune:":[615],"Bristol":[618],"Myers":[619],"Squibb:":[620],"Seattle":[623],"Genetics:":[624],"Membership":[625],"entity's":[628],"Board":[629],"Directors":[631],"advisory":[633],"committees;":[634],"Roche":[635],"Genentech:":[636],"Incyte:":[639],"Merck:":[642],"Funding.":[644]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}